Join us for a deep dive into the rapidly advancing field of regenerative medicine. This event brings together innovators working at the intersection of biology and engineering to explore how new approaches are reshaping the future of care.
About
-
How engineered tissues, gene-edited cells, and immune-modulating signals work together to drive functional regeneration
-
The scientific, manufacturing, and regulatory challenges of translating complex, biology-driven therapies into clinical practice
-
What founders, clinicians, and investors need to understand about building scalable, durable regenerative healthcare solutions
Shayn Peirce-Cottler – Session Moderator
Professor and Chair, Biomedical Engineering
University of Virginia
Stephen Kennedy
Head of Technical Operations
CRISPR Therapeutics
Ben Holmes
CEO
Nanochon
Don Griffin
Chief Scientific Officer
Tempo Therapeutics